ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $432,000 | +35.0% | 12,005 | +0.2% | 0.78% | +65.1% |
| Q2 2019 | $320,000 | -0.6% | 11,981 | 0.0% | 0.47% | +8.5% |
| Q1 2019 | $322,000 | +33.6% | 11,981 | -19.6% | 0.44% | -17.7% |
| Q4 2018 | $241,000 | -44.2% | 14,899 | -28.5% | 0.53% | -48.6% |
| Q3 2018 | $432,000 | +84.6% | 20,828 | +35.9% | 1.03% | +103.4% |
| Q2 2018 | $234,000 | -71.6% | 15,328 | -58.3% | 0.51% | -68.7% |
| Q1 2018 | $825,000 | +298.6% | 36,733 | +433.9% | 1.62% | +803.9% |
| Q4 2017 | $207,000 | -64.9% | 6,880 | -56.0% | 0.18% | -66.1% |
| Q3 2017 | $589,000 | +53.8% | 15,639 | +40.5% | 0.53% | +85.9% |
| Q1 2017 | $383,000 | +32.1% | 11,130 | +10.8% | 0.28% | +22.9% |
| Q4 2016 | $290,000 | – | 10,042 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |